 After the initial assessment and compliance with the eligibility criteria, participants will be randomized into an intervention group medication list will be evaluated by STOPPSTART criteria and a control group medication list will not be evaluated by STOPPSTART criteria. Randomization numbers will be generated by a random number generator. A series of numbered, sealed, opaque envelopes will be used to ensure confidentiality. Each envelope will contain a card with information about the group allocation. The group allocation is concealed from the researcher and patients at baseline registration. 